__timestamp | Grifols, S.A. | Incyte Corporation |
---|---|---|
Wednesday, January 1, 2014 | 1699214000 | 508491000 |
Thursday, January 1, 2015 | 1930998000 | 726779000 |
Friday, January 1, 2016 | 1912291000 | 1047532000 |
Sunday, January 1, 2017 | 2152011000 | 1456737000 |
Monday, January 1, 2018 | 2049560000 | 1787760000 |
Tuesday, January 1, 2019 | 2341232000 | 2044510000 |
Wednesday, January 1, 2020 | 2255165000 | 2535374000 |
Friday, January 1, 2021 | 1962596000 | 2835276000 |
Saturday, January 1, 2022 | 2231530000 | 3187638000 |
Sunday, January 1, 2023 | 2322701000 | 3440649000 |
Monday, January 1, 2024 | 3929149000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. This analysis compares the gross profit trends of Incyte Corporation and Grifols, S.A. from 2014 to 2023. Over this period, Incyte Corporation has shown a remarkable growth trajectory, with its gross profit increasing by approximately 577%, from $508 million in 2014 to $3.44 billion in 2023. This growth highlights Incyte's strategic advancements and market expansion.
Conversely, Grifols, S.A. has maintained a steady performance, with a 37% increase in gross profit, rising from $1.70 billion in 2014 to $2.32 billion in 2023. This stability underscores Grifols' consistent market presence and operational efficiency. The data reveals a compelling narrative of growth and stability, offering valuable insights for investors and industry analysts alike.
Key Insights on Gross Profit: Novartis AG vs Incyte Corporation
Gross Profit Comparison: Pfizer Inc. and Incyte Corporation Trends
Who Generates Higher Gross Profit? Incyte Corporation or Viatris Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Ascendis Pharma A/S
Cost of Revenue: Key Insights for Incyte Corporation and Grifols, S.A.
Who Generates Higher Gross Profit? Incyte Corporation or Corcept Therapeutics Incorporated
Gross Profit Analysis: Comparing Incyte Corporation and Alkermes plc
Gross Profit Comparison: Incyte Corporation and Veracyte, Inc. Trends
Key Insights on Gross Profit: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Viatris Inc. and Grifols, S.A. Trends
Gross Profit Trends Compared: Grifols, S.A. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Grifols, S.A. and Travere Therapeutics, Inc. Trends